Jump Financial’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,676
Closed -$65.7K 2270
2025
Q4
$65.7K Buy
+12,676
New +$61.4K ﹤0.01% 1858
2025
Q2
Sell
-100,918
Closed -$436K 2060
2025
Q1
$436K Buy
100,918
+2,968
+3% +$12K 0.01% 1131
2024
Q4
$313K Buy
+97,950
New +$329K 0.01% 1284
2024
Q1
Sell
-45,228
Closed -$185K 2189
2023
Q4
$185K Buy
+45,228
New +$127K 0.01% 1582
2023
Q1
Sell
-79,111
Closed -$213K 1937
2022
Q4
$213K Sell
79,111
-64,303
-45% -$188K 0.01% 1251
2022
Q3
$464K Buy
143,414
+107,410
+298% +$485K 0.02% 923
2022
Q2
$175K Buy
+36,004
New +$222K 0.01% 1340
2022
Q1
Sell
-32,900
Closed -$304K 1804
2021
Q4
$304K Buy
+32,900
New +$349K 0.02% 887
2021
Q3
Sell
-163,700
Closed -$2.72M 1391
2021
Q2
$2.72M Buy
163,700
+124,200
+314% +$2.32M 0.26% 47
2021
Q1
$720K Buy
39,500
+13,300
+51% +$180K 0.07% 308
2020
Q4
$197K Buy
+26,200
New +$124K 0.03% 788

Other funds holding ORGO

Jump Financial's ORGO Position: Q1 2026 in Review

Jump Financial sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 12,676 shares — an estimated $65.7K sold.

Jump Financial first reported a position in ORGO in Q4 2020 and held it in 11 quarters. The position peaked at $2.72M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Jump Financial reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 12,676 Organogenesis Holdings shares in Q1 2026, an estimated $65.7K.
  • Jump Financial first reported a position in Organogenesis Holdings in Q4 2020 and held it in 11 quarters.
  • Jump Financial's Organogenesis Holdings position peaked at $2.72M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.